Check SCREEN READER MODE to make this survey compatible with screen readers.
Colors of Systemic Mastocytosis Inspiration Application 2024-2025
Colors of SM: Expressions of Life with Systemic Mastocytosis is an artistic program for people who are living with or impacted by SM. The program will pair these individuals- the Inspiration - with volunteer artists who work in a variety of mediums to express the unique experiences of SM.
Blueprint Medicines, a global pharmaceutical company that aims to invent life-changing medicines in allergy/inflammation and oncology/hematology, has partnered with a national nonprofit organization, Twist Out Cancer, to develop an SM-specific program which will match volunteer artists with Inspirations. Twist Out Cancer offers customized creative arts programs to people living with a variety of health conditions.
To participate in this program, you must be a U.S. resident, 18 years or older, and have been diagnosed with SM or have been deeply impacted by SM as a caregiver, family or friend. Additional eligibility criteria and terms and conditions apply. Because of limited number of spots available, not all who apply may be able to participate in this program.
The resulting artwork will be owned by Blueprint Medicines, who will use it to raise awareness of SM through creative and impactful means, reaching the general public through both digital and in-person channels.
Twist Out Cancer asks the questions in this survey so that we can better understand those who are interested in participating in this program. Participation in this survey is completely voluntary and responses will only be considered in connection with Twist Out Cancer’s consideration of your application. Responses to demographic questions are for information only and will not be considered in connection with eligibility. Please understand that all responses you do provide will be kept confidential by Twist Out Cancer and will not be shared with Blueprint Medicines.
Blueprint Medicines and associated logo are trademarks of Blueprint Medicines Corporation.